Recombinant IL2RA (Basiliximab Biosimilar) antibody
-
- Target See all IL2RA (Basiliximab Biosimilar) products
- IL2RA (Basiliximab Biosimilar)
- Antibody Type
- Recombinant Antibody
-
Reactivity
- Human
-
Host
-
Human
- Expression System
- CHO Cells
-
Clonality
- Monoclonal
-
Conjugate
- This IL2RA (Basiliximab Biosimilar) antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), ELISA, Surface Plasmon Resonance (SPR), Functional Studies (Func), Bio-Layer Interferometry (BLI)
- Purpose
- Anti-IL-2Ra / CD25 Reference Antibody (basiliximab)
- Characteristics
- Anti-IL-2Ra / CD25 Reference Antibody (basiliximab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.58 kDa.
- Purity
- >95 %
- Isotype
- IgG1
-
anti-IL2RA (Basiliximab Biosimilar) antibody
Reactivity: Human, Cynomolgus, Rhesus Monkey FACS, BR, IF, IHC, WB Host: Rabbit Chimeric unconjugated Recombinant Antibody
anti-IL2RA (Basiliximab Biosimilar) antibodyReactivity: Human, Cynomolgus, Rhesus Monkey FACS, BR, IF, IHC, WB Host: Human Chimeric unconjugated Recombinant Antibody
anti-IL2RA (Basiliximab Biosimilar) antibodyResearch Grade Reactivity: Human FACS, ELISA Host: Mouse Chimeric unconjugated Recombinant Antibody
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- 1 mg/mL
- Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- Storage
- 4 °C,-80 °C
- Storage Comment
- +4°C,-80°C
-
- Target
- IL2RA (Basiliximab Biosimilar)
- Alternative Name
- IL-2Ra (Basiliximab Biosimilar) (IL2RA (Basiliximab Biosimilar) Products)
- Target Type
- Biosimilar
- Molecular Weight
- 145.58 kDa
- UniProt
- P01589
-
